Prader-Willi syndrome
Clinical research is centered on Prader-Willi syndrome, with attention to the neurological and behavioral burden associated with the condition.
- Excessive daytime sleepiness
- Sleep-wake disturbance
- Neurodevelopmental disorder
The sponsor’s activity in this area reflects a focused interest in symptoms that affect alertness, daily functioning, and quality of life in people living with this rare disorder.
Sleep medicine
Research interest extends to sleep medicine, particularly conditions involving impaired wakefulness and disrupted sleep regulation.
- Daytime sleepiness
- Wakefulness regulation
- Sleep-related symptoms
This area highlights therapeutic attention to symptoms that interfere with sustained attention, activity, and routine functioning.
Neurology and neurobehavioral care
The sponsor’s trial portfolio includes interest in neurological and neurobehavioral manifestations linked to a complex genetic disorder.
- Cognitive and behavioral symptoms
- Central nervous system regulation
- Rare disease neurology
These topics are relevant to symptom domains that shape long-term care needs in rare neurological disorders.
Rare disease therapeutics
Research activity is directed toward rare disease therapeutics, with emphasis on treatment options for a genetically defined pediatric and adult population.
- Genetic disorder management
- Symptom-focused therapy
- Orphan disease treatment
The therapeutic focus is concentrated on addressing a specific unmet need within Prader-Willi syndrome care.
